Brigham Young University and the pharmaceutical company Pfizer have reached a settlement.
BYU sought roughly $10 billion, claiming Pfizer took research done by BYU’s doctor Daniel Simmons toward production of the pain drug Celebrex.
On Tuesday morning, Pfizer released a statement regarding the pending case saying they reached a settlement with BYU. In the statement, Pfizer said the agreement was “amicable and on confidential terms.”
As part of the resolution, a Dan Simmons chair will be established at BYU in Recognition of Dr. Simmon’s work and contributions to the field of medicine.
A BYU spokesperson confirmed the settlement saying they are very pleased with the outcome.
Related: BYU in $10B civil suit with Pfizer